Extracellular vesicles (EVs) are cell-derived nanoparticles that facilitate transport of proteins, lipids, and genetic material, playing important roles in intracellular communication. They have remarkable potential as non-toxic and non-immunogenic...
Read More »EXOSOME NEWS
Liquid biopsies and future of cancer treatment
ASCO’s attendees witnessed a heightened focus on liquid biopsies, the noninvasive blood tests that detect multiple types of cancer, often at early stages as well as show whether or not a cancer has...
Read More »Coya Therapeutics Secures Option Agreement for Exclusive Worldwide Rights to Exosome Engineering Technology from Carnegie Mellon University
Coya Therapeutics announced the execution of an option agreement for exclusive worldwide rights to a novel and proprietary technology platform enabling...
Read More »UK study identifies therapeutic targets for Alzheimer’s disease
A new University of Kentucky College of Medicine study has identified potential targets to develop a therapy that could prevent Alzheimer’s disease. Alzheimer’s disease is the most common...
Read More »Featured Exosome Job – Scientist, Regenerative Medicine – Exosomes
Contribute to our expanding range of translational preventive and regenerative medicine work with exosomes from different source cells, including iPSCs and many iPSC-derived cell types like MSCs, HSCs,...
Read More »Size separation of exosomes and microvesicles using flow field-flow fractionation/multiangle light scattering
Extracellular vesicles (EVs) are cell-derived membrane-bound particles, including exosomes and microvesicles that differ in cellular origin, content, and lipid composition. This study reports that exosomes..
Read More »A tool to evaluate the exact EV-DNA role of cell-cell communication in cancer
Small extracellular vesicles (sEVs) play essential roles in intercellular signaling both in normal and pathophysiological conditions. Comprehensive...
Read More »Low-earth orbit spaceflight induces changes in circulating plasma small extracellular vesicle microRNA expression
A study led by researchers at Icahn School of Medicine at Mount Sinai suggests relatively short (median 12 days long) low‐Earth orbit (LEO) spaceflight induces changes in circulating plasma small ...
Read More »Circulating EV lipidome could harbor biomarkers for psoriasis
Psoriasis is a chronic immune-mediated inflammatory skin disorder affecting children and adults. To date no approved biomarkers for diagnosis of this disease and follow up of patients have been...
Read More »Post-doc position available – Clinical and Translational Research
We are seeking a Post-Doctoral Scientist -This position is in the Center for Clinical and Translational Research. We are seeking a motivated postdoctoral scholar to join our NIH-funded lab group that ...
Read More »Jobs
-
Featured Exosome Job – Scientist, Regenerative Medicine – Exosomes
Contribute to our expanding range of translational preventive and regenerative medicine work with exosomes from different source cells, including iPSCs and many iPSC-derived cell types like MSCs, HSCs,...
Read More » -
Post-doc position available – Clinical and Translational Research
-
Featured Exosome Job – Research Associate II, Exosome Engineering, Protein Sciences
-
Postdoc position available – microchip-based exosome sensors
-
Post-doc position available – new pathways in endosome formation and extracellular vesicle secretion in metastasis
Industry News
-
Codiak doses first patient with exoASO™-STAT6
Codiak BioSciences, a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a new class of medicines, today announced the...
Read More » -
NeuroSense Therapeutics Reports Positive Results from Stage III ALS Biomarker Study
-
Coya Therapeutics Secures Option Agreement for Exclusive Worldwide Rights to Exosome Engineering Technology from Carnegie Mellon University
-
Exosome Engineering Strategies for Cargo Loading and Targeting Delivery
-
Coya Therapeutics Secures $10 Million Financing to Advance Clinical and Pre-Clinical Pipeline of Treg-Derived Exosome Therapeutics